Serveur d'exploration Tocilizumab - Curation (Istex)

Index « ISSN » - entrée « Ann Rheum Dis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anal Bioanal Chem < Ann Rheum Dis < Appl Microbiol Biotechnol  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1036.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000327 (2009) N. Nishimoto [Japon] ; N. Miyasaka [Japon] ; K. Yamamoto [Japon] ; S. Kawai [Japon] ; T. Takeuchi [Japon] ; J. Azuma [Japon]Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
000328 (2011) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Kyoko Ito [Japon] ; Hisashi Yamanaka [Japon]Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
000336 (2009) M. Hirao [Japon] ; J. Hashimoto [Japon] ; H. Tsuboi [Japon] ; A. Nampei [Japon] ; H. Nakahara [Japon] ; N. Yoshio [Japon] ; T. Mima [Japon] ; H. Yoshikawa [Japon] ; N. Nishimoto [Japon]Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab
000338 (2012) Yusuf Yazici [États-Unis] ; Jeffrey R. Curtis [États-Unis] ; Akgun Ince [États-Unis] ; Herbert Baraf [États-Unis] ; Raymond L. Malamet [États-Unis] ; Lichen L. Teng [États-Unis] ; Arthur Kavanaugh [États-Unis]Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
000339 (2013) H. Uda [Japon] ; O. Saiki [Japon]FRI0186 Tocilizumab but not infliximab therapy induces myalgia among rheumatoid arthritis patients with high disease activity
000343 (2007) Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Norikazu Murata [Japon] ; Désirée Van Der Heijde [Pays-Bas] ; Tadamitsu Kishimoto [Japon]Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
000344 (2010) G. Jones [Australie] ; A. Sebba [États-Unis] ; J. Gu [République populaire de Chine] ; M B Lowenstein [États-Unis] ; A. Calvo [Pérou] ; J J Gomez-Reino [Espagne] ; D A Siri [Argentine] ; M. Tomši [Slovénie] ; E. Alecock [Royaume-Uni] ; T. Woodworth [Royaume-Uni] ; M C Genovese [États-Unis]Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
000345 (2013) J. J. Kim ; K. S. Na ; T. H. Kim ; D. H. YooTHU0466 Pilot Trial of Tocilizumab for Refractory Patients with Adult Onset Still’s Disease
000347 (2013) Monika M. Schoels [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho M. Murikama [Japon] ; Norihiro Nishimoto [Japon] ; Josef S. Smolen [Autriche]Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
000348 (2013) Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas]Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
000349 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules
000350 (2013) G. Horneff ; N. Onken ; A. Hospach [Allemagne] ; G. Ganser ; H. I. Huppertz [Allemagne]SAT0462 Experience with Tocilizumab in 29 Patients with Systemic Onset Juvenile Idiopathic Arthritis
000354 (2013) S. C. Horton [Royaume-Uni] ; S. Das [Royaume-Uni] ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. H. Buch [Royaume-Uni]AB0573 Tocilizumab use in a diverse patient population: Single-centre tertiary experience
000355 (2011) Pascale Louis-Plence [France] ; Yves-Marie Pers [France] ; Pierre Portales [France] ; Julie Quentin [France] ; Sylvie Fabre [France] ; Jean-François Eliaou [France] ; Christian Jorgensen [France]Longitudinal immunomonitoring following tocilizumab in rheumatoid arthritis
000358 (2011) A. Snir [Israël] ; A. Kessel [Israël] ; T. Haj [Israël] ; I. Rosner [Israël] ; M. Rozenbaum [Israël] ; G. Slobodin [Israël] ; E. Toubi [Israël]Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy
000359 (2011) Henrik Christian Leffers [Danemark] ; Mikkel Stergaard [Danemark] ; Bente Glintborg [Danemark] ; Niels Steen Krogh [Danemark] ; Heidi Foged [Danemark] ; Ulrik Tarp [Danemark] ; Tove Lorenzen [Danemark] ; Annette Hansen [Danemark] ; Michael Sejer Hansen [Danemark] ; Martin Skov Jacobsen [Danemark] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark]Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
000360 (2013) Stephanie Finzel [Allemagne] ; Juergen Rech [Allemagne] ; Sarah Schmidt [Allemagne] ; Klaus Engelke [Allemagne] ; Matthias Englbrecht [Allemagne] ; Georg Schett [Allemagne]Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study
000362 (2011) Juergen Rech [Allemagne] ; Monika Ronneberger [Allemagne] ; Matthias Englbrecht [Allemagne] ; Stephanie Finzel [Allemagne] ; Julia Katzenbeisser [Allemagne] ; Karin Manger [Allemagne] ; Bernhard Manger [Allemagne] ; Georg Schett [Allemagne]Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade
000363 (2013) C. Diaz-Torne ; M. A. Ortiz ; M. V. Hernandez [Espagne] ; D. Reina ; I. Castellví ; D. De La Fuente ; B. Magallares ; J. M. Ruiz-Martin ; H. Corominas [Espagne] ; C. Geli ; R. Sanmartí [Espagne] ; J. M. Llobet ; S. VidalAB0301 Characteristics of rheumatoid arthritis patients with adverse effects after the initiation of tocilizumab therapy
000364 (2013) N. Stein [Allemagne] ; M. Witt [Allemagne] ; M. Baeuerle [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Gruenke [Allemagne]THU0400 Inhibition of IL-6 signalling: A novel therapeutic approach for familial mediterranean fever
000365 (2013) M. Kostine ; T. Barnetche ; E. Ardouin ; M. Joly [France] ; E. Rabois [France] ; B. Glace [France] ; T. Schaeverbeke ; C. RichezFRI0192 Is early neutropenia associated with clinical response in patients receiving tocilizumab in rheumatoid arthritis?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/ISSN.i -k "Ann Rheum Dis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/ISSN.i  \
                -Sk "Ann Rheum Dis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    ISSN.i
   |clé=    Ann Rheum Dis
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021